As of 2025-07-13, the Relative Valuation of Gritstone Oncology Inc (GRTS) is (77.79) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.03 USD, the upside of Gritstone Oncology Inc based on Relative Valuation is -241674.2%.
The range of the Relative Valuation is (66.01) - (104.59) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.5x - 39.8x | 26.8x |
| Forward P/E multiples | 25.1x - 47.6x | 32.4x |
| Fair Price | (66.01) - (104.59) | (77.79) |
| Upside | -205111.6% - -324919.4% | -241674.2% |
| Date | P/E |